Publications

Nature biotechnology

Characterization of noncoding regulatory DNA in the human genome.

08-08-2017

Cell

Transcription Impacts the Efficiency of mRNA Translation via Co-transcriptional N6-adenosine Methylation.

06-04-2017

EMBO reports

TGFβ1-induced leucine limitation uncovered by differential ribosome codon reading.

01-04-2017

Methods in molecular biology (Clifton, N.J.)

GRO-seq, A Tool for Identification of Transcripts Regulating Gene Expression.

30-03-2017

Oncogene

microRNAs with AAGUGC seed motif constitute an integral part of an oncogenic signaling network.

09-02-2017

Nature reviews. Molecular cell biology

Applying CRISPR-Cas9 tools to identify and characterize transcriptional enhancers.

01-09-2016

Cell cycle (Georgetown, Tex.)

Monitoring amino acid deficiencies in cancer.

01-09-2016

Oncogene

A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response.

18-08-2016

Nature

Tumour-specific proline vulnerability uncovered by differential ribosome codon reading.

25-02-2016

Circulation research

Genome-Wide Polyadenylation Maps Reveal Dynamic mRNA 3'-End Formation in the Failing Human Heart.

05-02-2016

PLoS genetics

3'UTR Shortening Potentiates MicroRNA-Based Repression of Pro-differentiation Genes in Proliferating Human Cells.

01-02-2016

Nature biotechnology

Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9.

01-02-2016

EMBO reports

Myc coordinates transcription and translation to enhance transformation and suppress invasiveness.

01-12-2015

The international journal of biochemistry & cell biology

Exposure to arginine analog canavanine induces aberrant mitochondrial translation products, mitoribosome stalling, and instability of the mitochondrial proteome.

01-08-2015

Expert opinion on biological therapy

Enhancer-associated RNAs as therapeutic targets.

01-05-2015

Nature communications

Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA.

27-03-2015

Molecular cell

Transcription initiation determines its end.

22-01-2015

Cancer research

miR-155 drives telomere fragility in human breast cancer by targeting TRF1.

01-08-2014

Nature communications

Ribosome profiling reveals features of normal and disease-associated mitochondrial translation.

05-12-2013

The EMBO journal

Lncing protein translation to metastasis.

16-10-2013

Clinical cancer research : an official journal of the American Association for Cancer Research

Identification of lethal microRNAs specific for head and neck cancer.

15-10-2013

Cell research

eRNAs reach the heart of transcription.

01-10-2013

Nucleic acids research

A versatile microsatellite instability reporter system in human cells.

01-09-2013

Nature reviews. Genetics

Alternative cleavage and polyadenylation: extent, regulation and function.

01-07-2013

Molecular cell

eRNAs are required for p53-dependent enhancer activity and gene transcription.

07-02-2013

Clinical cancer research : an official journal of the American Association for Cancer Research

Alternative cleavage and polyadenylation during colorectal cancer development.

01-10-2012

Cell

The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites.

27-04-2012

Nature communications

Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity.

25-10-2011

PloS one

3'UTR-mediated gene silencing of the Mixed Lineage Leukemia (MLL) gene.

15-10-2011

Nature reviews. Cancer

MicroRNA regulation by RNA-binding proteins and its implications for cancer.

05-08-2011

Nature cell biology

A Pumilio-induced RNA structure switch in p27-3' UTR controls miR-221 and miR-222 accessibility.

01-10-2010

BMC genomics

Major role for mRNA stability in shaping the kinetics of gene induction.

21-04-2010

European journal of clinical investigation

microRNAs, RNA binding proteins and cancer.

01-04-2010

Nature cell biology

BRD7 is a candidate tumour suppressor gene required for p53 function.

01-04-2010

Genes & development

Tumorigenicity of the miR-17-92 cluster distilled.

01-01-2010

Cell

Transformation locked in a loop.

13-11-2009

The FEBS journal

The miRNA-192/194 cluster regulates the Period gene family and the circadian clock.

01-10-2009

PLoS computational biology

Removal of AU bias from microarray mRNA expression data enhances computational identification of active microRNAs.

03-10-2008

Cell

A PASport to cellular proliferation.

25-07-2008

Cancer research

Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer.

15-07-2008

RNA (New York, N.Y.)

miR-148 targets human DNMT3b protein coding region.

01-05-2008

Cell cycle (Georgetown, Tex.)

Interplay between microRNAs and RNA-binding proteins determines developmental processes.

01-04-2008

Cell

RNA-binding protein Dnd1 inhibits microRNA access to target mRNA.

28-12-2007

Cell cycle (Georgetown, Tex.)

Diverse ways to control p27Kip1 function: miRNAs come into play.

15-11-2007

Advances in experimental medicine and biology

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

19-08-2007

The EMBO journal

Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.

08-08-2007

Cell

All roads lead to IKKepsilon.

15-06-2007

Biochimica et biophysica acta

Classifying microRNAs in cancer: the good, the bad and the ugly.

01-06-2007

The Journal of biological chemistry

Telomerase-independent regulation of ATR by human telomerase RNA.

29-12-2006

Cell cycle (Georgetown, Tex.)

Immense promises for tiny molecules: uncovering miRNA functions.

01-07-2006

Characterization of noncoding regulatory DNA in the human genome.

Transcription Impacts the Efficiency of mRNA Translation via Co-transcriptional N6-adenosine Methylation.

TGFβ1-induced leucine limitation uncovered by differential ribosome codon reading.

GRO-seq, A Tool for Identification of Transcripts Regulating Gene Expression.

microRNAs with AAGUGC seed motif constitute an integral part of an oncogenic signaling network.

Applying CRISPR-Cas9 tools to identify and characterize transcriptional enhancers.

Monitoring amino acid deficiencies in cancer.

A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response.

Tumour-specific proline vulnerability uncovered by differential ribosome codon reading.

Genome-Wide Polyadenylation Maps Reveal Dynamic mRNA 3'-End Formation in the Failing Human Heart.

3'UTR Shortening Potentiates MicroRNA-Based Repression of Pro-differentiation Genes in Proliferating Human Cells.

Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9.

Myc coordinates transcription and translation to enhance transformation and suppress invasiveness.

Exposure to arginine analog canavanine induces aberrant mitochondrial translation products, mitoribosome stalling, and instability of the mitochondrial proteome.

Enhancer-associated RNAs as therapeutic targets.

Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA.

Transcription initiation determines its end.

miR-155 drives telomere fragility in human breast cancer by targeting TRF1.

Ribosome profiling reveals features of normal and disease-associated mitochondrial translation.

Lncing protein translation to metastasis.

Identification of lethal microRNAs specific for head and neck cancer.

eRNAs reach the heart of transcription.

A versatile microsatellite instability reporter system in human cells.

Alternative cleavage and polyadenylation: extent, regulation and function.

eRNAs are required for p53-dependent enhancer activity and gene transcription.

Alternative cleavage and polyadenylation during colorectal cancer development.

The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites.

Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity.

3'UTR-mediated gene silencing of the Mixed Lineage Leukemia (MLL) gene.

MicroRNA regulation by RNA-binding proteins and its implications for cancer.

A Pumilio-induced RNA structure switch in p27-3' UTR controls miR-221 and miR-222 accessibility.

Major role for mRNA stability in shaping the kinetics of gene induction.

microRNAs, RNA binding proteins and cancer.

BRD7 is a candidate tumour suppressor gene required for p53 function.

Tumorigenicity of the miR-17-92 cluster distilled.

Transformation locked in a loop.

The miRNA-192/194 cluster regulates the Period gene family and the circadian clock.

Removal of AU bias from microarray mRNA expression data enhances computational identification of active microRNAs.

A PASport to cellular proliferation.

Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer.

miR-148 targets human DNMT3b protein coding region.

Interplay between microRNAs and RNA-binding proteins determines developmental processes.

RNA-binding protein Dnd1 inhibits microRNA access to target mRNA.

Diverse ways to control p27Kip1 function: miRNAs come into play.

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.

All roads lead to IKKepsilon.

Classifying microRNAs in cancer: the good, the bad and the ugly.

Telomerase-independent regulation of ATR by human telomerase RNA.

Immense promises for tiny molecules: uncovering miRNA functions.

This site uses cookies